secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2026-09-28T10:14:09+00:00
Accession:  0001493152-26-044421
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Celularity raises $11.01M in secured convertibles at $1.50; up to $25M total; Barach joins board
--------------------------------------------------------------------------------

- Initial closing Sept 24, 2026: $11.01M principal of senior secured convertible notes at $1.50/share conversion, plus warrants for ~4,037,000 shares at $1.50.
- Total facility up to $25.0M: Tranche 1 up to $15.0M; Tranche 2 up to $10.0M at purchaser election through Sept 30, 2027 at $2.00/share conversion.
- Notes bear 10% interest compounding annually (15% on default), mature 24 months; warrants run 5 years; conversion/exercise floor is $1.25; security interest covers substantially all assets.
- Helena settlement: $1.197M note converted at $1.71 into 700,000 shares plus 2,000,000 additional shares; Helena assigns $1.25M of its $2.5M NEXGEL note to Celularity.
- Geoffrey Ling resigned from the board Sept 24, 2026; Philip A. Barach appointed under the Board Rights Agreement; Nasdaq stockholder approval due by Dec 19, 2026 or prices cut 10%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226044421/0001493152-26-044421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226044421/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-044421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer